AMI Investment Management Inc. Reduces Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

AMI Investment Management Inc. lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 5.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,905 shares of the healthcare conglomerate’s stock after selling 303 shares during the quarter. AMI Investment Management Inc.’s holdings in UnitedHealth Group were worth $2,582,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the stock. Richelieu Gestion SA bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $26,000. Robbins Farley purchased a new position in UnitedHealth Group during the third quarter worth $25,000. CGC Financial Services LLC boosted its stake in UnitedHealth Group by 1,000.0% during the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 50 shares during the period. NewSquare Capital LLC lifted its stake in UnitedHealth Group by 340.0% in the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 51 shares during the period. Finally, Strategic Investment Solutions Inc. IL acquired a new position in shares of UnitedHealth Group during the first quarter valued at about $35,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.3 %

UNH opened at $494.70 on Friday. The stock has a market capitalization of $456.08 billion, a price-to-earnings ratio of 20.75, a price-to-earnings-growth ratio of 1.34 and a beta of 0.54. UnitedHealth Group Incorporated has a 12 month low of $445.68 and a 12 month high of $554.70. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.79 and a quick ratio of 0.79. The business has a 50-day moving average of $503.10 and a two-hundred day moving average of $518.61.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, topping the consensus estimate of $5.98 by $0.18. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The firm had revenue of $94.43 billion for the quarter, compared to analyst estimates of $92.13 billion. During the same period in the previous year, the company posted $5.34 EPS. UnitedHealth Group’s revenue for the quarter was up 14.1% on a year-over-year basis. On average, research analysts expect that UnitedHealth Group Incorporated will post 27.82 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio (DPR) is 31.54%.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the stock. Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Stephens restated an “overweight” rating and issued a $605.00 price objective on shares of UnitedHealth Group in a research report on Thursday, February 8th. Bank of America restated a “buy” rating and issued a $675.00 price objective on shares of UnitedHealth Group in a research report on Thursday, March 7th. Oppenheimer restated an “outperform” rating and issued a $610.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, January 17th. Finally, Truist Financial reissued a “buy” rating and issued a $610.00 price target on shares of UnitedHealth Group in a research note on Thursday, November 30th. One analyst has rated the stock with a sell rating, two have issued a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average target price of $579.33.

Read Our Latest Research Report on UnitedHealth Group

Insider Buying and Selling

In other news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.